Global Liver Treatment Market to Witness Huge Growth in 2025 | Key Player Analysis: Siemens AG, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies
The global liver treatment market is expected to reach US$ 4,883.5 Mn in 2025 from US$ 3,426.8 Mn in 2017. The market is estimated to grow with a CAGR of 4.6% from 2018-2025.
Get Sample Copy of this Report at: http://bit.ly/2S8z6pX
Liver carries out an essential function of digesting food as well as elimination of toxic substances from the body. A liver disease can either be inherited or may occur due to various factors such as, viruses or excessive consumption of alcohol, eventually leading to fatal condition called, liver cirrhosis. Liver diseases can be diagnosed by methods such as, blood tests, tissue analysis and imaging tests. The imaging modalities covered in the report include, magnetic resonance imaging (MRI), computed tomography (CT) and ultrasound. Key factors driving the market are the increase in the number of liver disease cases, technological advancements in imaging and rising geriatric population at a higher risk of developing liver disease.
Leading Liver Treatment Market Players:
1. General Electric
2. Koninklijke Philips N.V.
3. Siemens AG
4. CANON MEDICAL SYSTEMS CORPORATION
5. Hitachi, Ltd
6. Elekta AB (pub)
7. Neusoft Corporation
8. Samsung Healthcare
9. BPL Medical Technologies
10. Cura Healthcare
Liver treatment market is segmented into disease and imaging modality. On the basis of disease, the market is segmented into cirrhosis, hepatitis, cancer and other diseases. The liver treatment market is segmented as, magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, and other modalities, based on imaging modality.
The report would be of an interest to various stakeholders operating in the liver treatment market. These stakeholders include healthcare institutes, research institutes, liver treatment product manufacturers and vendors, research consulting firms, liver treatment service providers, distributors and others.
The objective of the study is to describe, define, and forecast the liver treatment market by disease and imaging modality, and region. The report also provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall liver treatment market.
Inquire about this Report at: http://bit.ly/2OF1X76
The report analyzes factors affecting market from both demand and supply side and further evaluates liver treatment market dynamics effecting the liver treatment market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.
Some of the prominent players operating in liver treatment market are General Electric, Koninklijke Philips N.V., Siemens AG, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies, and Cura Healthcare. The market players are indulged into development of novel and innovative products to cater the demands of users in the liver treatment market. For instance, in March 2018, GE Healthcare launched LOGIQ. This system offers 48 times the data throughput and 10 times the processing power of the existing systems and is capable of spotting lesions in the liver, thus enabling better diagnosis of the medical condition
Reason to Buy:
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Liver Treatment Market
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Liver Treatment Market, thereby allowing players to develop effective long term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.
Ask For Discount at: http://bit.ly/2NZzh3s
Table of Contents:
1. INTRODUCTION 14
1.1 SCOPE OF THE STUDY 14
1.2 THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE 14
2. GLOBAL LIVER TREATMENT MARKET – KEY TAKEAWAYS 15
3. GLOBAL LIVER TREATMENT MARKET – MARKET LANDSCAPE 17
3.1 OVERVIEW 17
3.2 MARKET SEGMENTATION 17
3.2.1 Global Liver Treatment Market – By Disease 18
3.2.2 Global Liver Treatment Market – By Imaging Modality 18
3.2.3 Global Liver Treatment Market – By Geography 19
4. GLOBAL LIVER TREATMENT MARKET – KEY MARKET DYNAMICS 20
4.1 KEY MARKET DRIVERS 20
4.1.1 Increasing Prevalence of Liver Diseases 20
4.1.2 Increasing Geriatric Population 20
4.1.3 Technological Advancements in Imaging Techniques 21
4.2 KEY MARKET RESTRAINTS 21
4.2.1 Stringent Regulatory Validation Requirement 21
4.2.2 High Cost of Imaging Techniques 21
4.3 KEY MARKET OPPORTUNITIES 22
4.3.1 Partnerships and Collaborations Between Market Players 22
4.3.2 Increasing Healthcare Expenditures in Emerging Markets 22
4.4 FUTURE TRENDS 23
4.4.1 Increasing Use of Hybrid Systems for Imaging 23
4.5 IMPACT ANALYSIS 24
5. LIVER TREATMENT MARKET –GLOBAL ANALYSIS 25
5.1 LIVER TREATMENT MARKET REVENUE FORECASTS AND ANALYSIS 25
5.2 GLOBAL LIVER TREATMENT MARKET, BY GEOGRAPHY - FORECASTS AND ANALYSIS 25
5.3 EXPERT OPINIONS 26
Buying this Customized Report at: http://bit.ly/2OKaQfV
The Insight Partners is a one top industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Liver Treatment Market to Witness Huge Growth in 2025 | Key Player Analysis: Siemens AG, CANON MEDICAL SYSTEMS CORPORATION, Hitachi, Ltd, Elekta AB (pub), Neusoft Corporation, Samsung Healthcare, BPL Medical Technologies here
News-ID: 1320082 • Views: 156
More Releases from The Insight Partners
New Study on PC as a Service Market to 2027 - Lenovo, Dell, Hewlett Packard Ente …
The analysis of the global PC as a Service Market 2027 is an in-depth study of the PC as a Service industry, which focuses on global market trends. The report aims to provide an overview of the global market for PC as a Service with detailed market segmentation by product / application and by region. The global market for PC as a Service is expected to experience strong Growth over
New Syudy on IoT Gateway Market to 2027 - AAEON Technology, Adlink Technology, A …
The analysis of the global IoT Gateway Market 2027 is an in-depth study of the IoT Gateway industry, which focuses on global market trends. The report aims to provide an overview of the global market for IoT Gateway with detailed market segmentation by product / application and by region. The global market for IoT Gateway is expected to experience strong Growth over the forecast period. The reports cover key market developments
Enterprise Content Management System Market Projected to Garner Significant Reve …
The Industry Report “Enterprise Content Management System Market” provides a clear picture of the Current Market Scenario which includes past and estimated future size with respect to value and volume, technological advancement, macro economical and governing factors in the Enterprise Content Management System market. Enterprise Content Management System is a tool that provides a centralized platform to hold the content and manage it in such a way that it meets regulatory
Li-Fi Enabled Communication System Market to Witness an Outstanding Growth durin …
Growing demand for cost and energy efficient wireless communication systems to drive the Li-Fi Enabled Communication System market worldwide With the technological advancements in the digital world and the existing wireless communication infrastructures proving to be incapable of handling the predicted surge in the number of connected devices as well as the data traffic over the network, the search for new emerging communication system with better data traffic handling capabilities has
More Releases for Liver
Global Liver Detox Market Research Report
This report studies the global Liver Detox market status and forecast, categorizes the global Liver Detox market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Health Plus(UK) Swisse(AU) ReNew Life Formulas, Inc.(US) NATURE' S BOUNTY(US) Healthy Care(AU) Evolution Slimming Ltd(UK) PureFormulas Inc.
Liver Cirrhosis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Cirrhosis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Cirrhosis - Pipeline Review, H1 2017, provides an overview of the Liver Cirrhosis (Gastrointestinal) pipeline landscape. Cirrhosis is scarring of the liver caused by many forms of liver diseases and conditions, such as hepatitis and
Liver Transplant Rejection - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Liver Transplant Rejection - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Liver Transplant Rejection - Pipeline Review, H1 2017, provides an overview of the Liver Transplant Rejection (Immunology) pipeline landscape. Liver transplantation is the conventional therapy used in various liver diseases. Liver has the unique ability
Global Liver Disease Treatment Market
The Liver Disease Treatment Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies. The liver is one of the most important organs of the human body and performs major functions, such as removal of harmful substances from blood, maintains adequate level of chemicals
Liver Extract Power Exporter, Liver Extract Product, Liver Extract Crude, Liver …
Titan Biotech is an ISO 9001:2000 Certified Company, established with an objective of serving Scientific Community and providing good quality of Biological Products, Biotechnology Products, Biological Extracts and their derivatives. Liver Extract Power Exporter is produced from specific fraction of beef liver. Liver Extract is rich in vital nutrients including energy producing B Vitamins and serve as an excellent source of proteins. Liver Extract is capable of stimulating the production
Liver Disease Diagnostics by Immunoblot Test System
Mainz based ORGENTEC Diagnostika GmbH has developed a new immunoblot test for the serological diagnosis of autoimmune liver disease. Liver-9-Line facilitates the rapid and cost-effective diagnosis of autoimmune hepatitis (type 1 and type 2 AIH) and primary biliary cirrhosis (PBC) in a single step. The test system also allows for the reliable differentiation of these autoimmune diseases from other diseases of the liver. This immunoblot is suitable for initial and differential